Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.53 |
| ▸ | TSHR | P16473 | 1/20 | 0.53 |
| ▸ | DNM1 | Q05193 | 3/20 | 0.43 |
| ▸ | TDP1 | Q9NUW8 | 3/20 | 0.37 |
| ▸ | CA12 | O43570 | 1/20 | 0.37 |
| ▸ | CA2 | P00918 | 1/20 | 0.37 |
| ▸ | CA3 | P07451 | 1/20 | 0.37 |
| ▸ | CA4 | P22748 | 1/20 | 0.37 |
| ▸ | CA6 | P23280 | 1/20 | 0.37 |
| ▸ | CA5A | P35218 | 1/20 | 0.37 |
| ▸ | CA7 | P43166 | 1/20 | 0.37 |
| ▸ | CA9 | Q16790 | 1/20 | 0.37 |
| ▸ | CA14 | Q9ULX7 | 1/20 | 0.37 |
| ▸ | CA5B | Q9Y2D0 | 1/20 | 0.37 |
| ▸ | HTR2A | P28223 | 1/20 | 0.36 |
| ▸ | HRH1 | P35367 | 1/20 | 0.36 |
| ▸ | MAPT | P10636 | 1/20 | 0.35 |
| ▸ | CYP1A2 | P05177 | 2/20 | 0.32 |
| ▸ | HRH4 | Q9H3N8 | 2/20 | 0.32 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.32 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL15620 | 0.86 | ALDH1A1 (0.60) | ALDH1A1TSHRDNM1TDP1CA12 | |
| SCHEMBL23939990 | 0.83 | ALDH1A1 (0.67) | ALDH1A1TSHRDNM1TDP1CA12 | |
| SCHEMBL23923650 | 0.83 | ALDH1A1 (0.67) | ALDH1A1TSHRDNM1TDP1CA12 | |
| SCHEMBL1290871 | 0.82 | ALDH1A1 (0.75) | ALDH1A1TSHRDNM1TDP1CA12 | |
| SCHEMBL212626 | 0.82 | — | — | |
| SCHEMBL15214946 | 0.79 | ALDH1A1 (0.38) | ALDH1A1TSHRDNM1TDP1CA12 | |
| SCHEMBL757212 | 0.79 | ALDH1A1 (0.71) | ALDH1A1TSHRDNM1TDP1CA12 | |
| Bromide SCHEMBL30558707 | 0.78 | ALDH1A1 (0.69) | ALDH1A1TSHRDNM1TDP1CA12 | |
| SCHEMBL10790523 | 0.78 | ALDH1A1 (0.83) | ALDH1A1TSHRDNM1TDP1CA12 | |
| SCHEMBL26135085 | 0.78 | ALDH1A1 (0.69) | ALDH1A1TSHRDNM1TDP1CA12 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 84 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-3861977-B1 | (METH)ACRYLATE, MONOMER COMPOSITION, MOLDED BODY, COMPOSITION FOR DENTAL MATERIAL, AND DENTAL MATERIAL | MITSUI CHEMICALS INC (JP) | 2026-05-06 | — | — | EP | disclosed |
| US-12441821-B2 | (Meth)acrylate and use thereof | MITSUI CHEMICALS, INC. (JP) | 2025-10-14 | — | — | US | disclosed |
| US-20250122315-A1 | (METH)ACRYLATE AND USE THEREOF | MITSUI CHEMICALS, INC. (JP) | 2025-04-17 | — | — | US | disclosed |
| US-12275814-B2 | (Meth)acrylate, monomer composition, molded body, composition for dental material, and dental material | MITSUI CHEMICALS, INC. (JP) | 2025-04-15 | — | — | US | disclosed |
| EP-3719043-B1 | (METH)ACRYLATE, MONOMER COMPOSITION, DENTAL MATERIAL OBTAINED FROM SAID COMPOSITION, AND PRODUCTION METHOD THEREOF | MITSUI CHEMICALS INC (JP) | 2024-11-13 | — | — | EP | disclosed |
| US-12098236-B2 | Monomer composition and production method thereof, raw material composition, curable composition, and molded body | MITSUI CHEMICALS, INC. (JP) | 2024-09-24 | — | — | US | disclosed |
| US-11786444-B2 | Dental polyfunctional monomers and dental hydroxyl group-containing monomers | MITSUI CHEMICALS, INC. (JP) | 2023-10-17 | — | — | US | disclosed |
| EP-3603607-B1 | MULTIFUNCTIONAL MONOMER FOR DENTAL MATERIAL, AND HYDROXYL GROUP-CONTAINING MONOMER FOR DENTAL MATERIAL | MITSUI CHEMICALS INC (JP) | 2023-09-20 | — | — | EP | disclosed |
| US-20220275125-A1 | URETHANE ALLYL COMPOUND, MONOMER COMPOSITION, MOLDED BODY, COMPOSITION FOR DENTAL MATERIAL, AND DENTAL MATERIAL | MITSUI CHEMICALS, INC. (JP) | 2022-09-01 | — | — | US | disclosed |
| US-11406571-B2 | Dental polyfunctional monomers and dental hydroxyl group-containing monomers | MITSUI CHEMICALS, INC. (JP) | 2022-08-09 | — | — | US | disclosed |
| EP-1447866-A1 | POSITIVE ELECTRODE ACTIVE MATERIAL FOR LITHIUM SECONDARY CELL AND LITHIUM SECONDARY CELL | Yuasa Corporation (JP) | 2004-08-18 | — | — | EP | disclosed |
| EP-1391950-A1 | ANODE ACTIVE MATTER AND PRODUCTION METHOD THEREFOR, NON- AQUEOUS ELECTROLYTE SECONDARY BATTERY-USE ANODE, AND NON-AQUEOUS ELECTROLYTE SECONDARY BATTERY | Yuasa Corporation (JP) | 2004-02-25 | — | — | EP | disclosed |
| EP-1233990-B1 | METHOD FOR PRODUCING MANNICH ADDUCTS THAT CONTAIN POLYISOBUTYLENE PHENOL | BASF AG (DE) | 2004-02-18 | — | — | EP | disclosed |
| EP-1372202-A1 | POSITIVE ELECTRODE ACTIVE MATERIAL AND NONAQUEOUS ELECTROLYTE SECONDARY CELL COMPRISING THE SAME | Yuasa Corporation (JP) | 2003-12-17 | — | — | EP | disclosed |
| US-20030064282-A1 | Battery-use separator, battery-use power generating element and battery | GS YUASA CORPORATION (JP) | 2003-04-03 | — | — | US | disclosed |
| EP-1271673-A1 | BATTERY-USE SEPARATOR, BATTERY-USE POWER GENERATING ELEMENT AND BATTERY | Yuasa Corporation (JP) | 2003-01-02 | — | — | EP | disclosed |
| EP-1233990-A1 | METHOD FOR PRODUCING MANNICH ADDUCTS THAT CONTAIN POLYISOBUTYLENE PHENOL | BASF AKTIENGESELLSCHAFT (DE) | 2002-08-28 | — | — | EP | disclosed |
| WO-2001025293-A1 | METHOD FOR PRODUCING MANNICH ADDUCTS THAT CONTAIN POLYISOBUTYLENE PHENOL | BASF AKTIENGESELLSCHAFT (DE) | 2001-04-12 | — | — | WO | disclosed |
| US-4175097-A | Bis(dimethylaminopropyl)-amine derivatives as polyurethane catalysts | TEXACO DEVELOPMENT CORP. (US) | 1979-11-20 | — | — | US | disclosed |
| US-4101466-A | Bis (dimethylaminopropyl)-amine derivatives as polyurethane catalysts | TEXACO DEVELOPMENT CORP. (US) | 1978-07-18 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (6 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-12098236-B2 | Monomer composition and production method thereof, raw material composition, curable composition, and molded body | MMAB, MAT1A, ACMSD | ALDH1A1 671/4885TSHR 4671/4885DNM1 4108/4885 |
| US-11786444-B2 | Dental polyfunctional monomers and dental hydroxyl group-containing monomers | PAM, CAD, FHIT | ALDH1A1 1173/4885TSHR 2948/4885DNM1 680/4885 |
| US-20250122315-A1 | (METH)ACRYLATE AND USE THEREOF | TST, MMAB, BHMT2 | ALDH1A1 144/4885TSHR 2952/4885DNM1 4294/4885 |
| US-11406571-B2 | Dental polyfunctional monomers and dental hydroxyl group-containing monomers | PAM, CAD, FHIT | ALDH1A1 1173/4885TSHR 2948/4885DNM1 680/4885 |
| US-12275814-B2 | (Meth)acrylate, monomer composition, molded body, composition for dental material, and dental material | MMAB, CAD, ALG3 | ALDH1A1 369/4885TSHR 2885/4885DNM1 3407/4885 |
| US-12441821-B2 | (Meth)acrylate and use thereof | TST, MMAB, BHMT2 | ALDH1A1 144/4885TSHR 2952/4885DNM1 4294/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.